SARS-CoV Mediated Modulation of Innate Immunity
SARS-CoV Mediated Modulation of Innate Immunity
批准号:
7266327
负责人:
Matthew Bryan Frieman
金额:
$5.04万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2008-07-31
关键词:
AntibodiesAntiviral ResponseApoptosisApoptoticAsiaBiological AssayCellsCessation of lifeChinaClassificationConsensus SequenceCoronavirusCoronavirus InfectionsDiseaseDisease OutbreaksEconomicsEpithelialEpithelial CellsEuropeFellowshipGene OrderGenesGenomeGoalsGrowthHumanIRF3 geneImmune responseIn VitroIndividualInfectionInterferon ActivationInterferonsLengthLocationMeasurementMeasuresMediatingModelingMusMutationNamesNatural ImmunityNorth AmericaOpen Reading FramesOutcomePathogenesisPathway interactionsPhenotypePopulationProductionProteinsProvinceRNA chemical synthesisRecombinant DNARecombinantsReportingReverse Transcriptase Polymerase Chain ReactionSTAT1 geneSTAT3 geneSevere Acute Respiratory SyndromeSignal TransductionSiteSourceStandards of Weights and MeasuresStructural ProteinTechniquesTestingVariantViralVirusVirus DiseasesVirus Replicationcellular targetingcytokinefallsfunctional restorationhuman coronavirusin vitro Modelin vivomouse modelmutantprotein Eprotein expressionrecombinant virusreplicaseresponsevirus pathogenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Severe acute respiratory syndrome (SARS) is a potentially fatal disease that appears to have originated in the Guandong Province of China in the fall of 2002. The disease is caused by a new human coronavirus (CoV), named the SARS-CoV, which is unlike any previous known coronavirus, but classified among the group II coronaviruses like MHV. The goals of this proposal include the systematic deletion of each accessory ORF singly and then in combinations of the accessory ORFs of the SARS-CoV. I will use these deletion mutants to test the hypothesis that one or more accessory ORFs are responsible for modulating the host innate immune response. I will analyze the anti-viral response in Caco2, MA104 and Human Airway Epithelial (HAE) cells to establish at what level in the anti-viral pathway the interferon-antagonist proteins of SARS are acting, as well as how mutants in these SARS genes effect pathogenesis.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.virusres.2007.03.015
发表时间:
2008-04
期刊:
VIRUS RESEARCH
影响因子:
5
作者:
[Frieman, Matthew, Heise, Mark, Baric, Ralph]
通讯作者:
Baric, Ralph
Coronavirus Challenge Core
-
批准号:10420513
-
项目类别:
-
资助金额:$144.15万
-
财政年份:2022
-
负责人:Matthew Bryan Frieman
-
依托单位:
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
-
批准号:10183158
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10649491
-
项目类别:
-
资助金额:$55.08万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10196973
-
项目类别:
-
资助金额:$55.69万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of Diabetes in MERS Coronavirus Pathogenesis
-
批准号:10418670
-
项目类别:
-
资助金额:$55.24万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Broad Spectrum Anti-viral Compounds Targeting the SKI Complex
-
批准号:10038144
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2020
-
负责人:Matthew Bryan Frieman
-
依托单位:
Diabetic Comorbidity and MERS Coronavirus Pathogenesis
-
批准号:9294969
-
项目类别:
-
资助金额:$19.54万
-
财政年份:2016
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8878023
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8683089
-
项目类别:
-
资助金额:$52.85万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8290205
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:9275569
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8161787
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Role of the Epithelial Growth Factor Receptor in SARS Coronavirus Pathogenesis
-
批准号:8500163
-
项目类别:
-
资助金额:$48.56万
-
财政年份:2011
-
负责人:Matthew Bryan Frieman
-
依托单位:
Inhibition of the Innate Immune Response by the SARS Coronavirus
-
批准号:7874578
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2009
-
负责人:Matthew Bryan Frieman
-
依托单位:
Inhibition of the Innate Immune Response by the SARS Coronavirus
-
批准号:7532181
-
项目类别:
-
资助金额:$15.83万
-
财政年份:2009
-
负责人:Matthew Bryan Frieman
-
依托单位:
SARS-CoV Mediated Modulation of Innate Immunity
-
批准号:7099465
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2005
-
负责人:Matthew Bryan Frieman
-
依托单位:
SARS-CoV Mediated Modulation of Innate Immunity
-
批准号:6997685
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2005
-
负责人:Matthew Bryan Frieman
-
依托单位:
海外基金